2005
DOI: 10.1021/jm049252r
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Based Design, Parallel Synthesis, Structure−Activity Relationship, and Molecular Modeling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives

Abstract: In this paper we describe our structure-based ligand design, synthetic strategy, and structure-activity relationship (SAR) studies that led to the identification of thiocarbamates (TCs), a novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), isosteres of phenethylthiazolylthiourea (PETT) derivatives. Assuming as a lead compound O-[2-(phthalimido)ethyl]phenylthiocarbamate 12, one of the precursors of the previously described acylthiocarbamates (Ranise, A.; et al. J. Med. Chem. 2003, 46, 768-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
28
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 64 publications
4
28
0
Order By: Relevance
“…The cytoprotection data reported by Ranise et al [25] have been used as the model dataset for the present study: the cytoprotection data [EC 50 (50% effective concentration in mM)] of substituted thiocarbamates (Table 1) have been converted to the logarithmic scale (pEC 50 or À logEC 50 where EC 50 is in mM) and then used for subsequent QSAR analyses as the response variable. There are four regions of structural variations in the compounds: one is the R position of the phenyl ring (showing diverse substitution pattern) and the remaining are R 1 , R 2 , and B 1/2 positions (showing limited substitution pattern) ( Table 1).…”
Section: The Dataset and Descriptorsmentioning
confidence: 99%
See 1 more Smart Citation
“…The cytoprotection data reported by Ranise et al [25] have been used as the model dataset for the present study: the cytoprotection data [EC 50 (50% effective concentration in mM)] of substituted thiocarbamates (Table 1) have been converted to the logarithmic scale (pEC 50 or À logEC 50 where EC 50 is in mM) and then used for subsequent QSAR analyses as the response variable. There are four regions of structural variations in the compounds: one is the R position of the phenyl ring (showing diverse substitution pattern) and the remaining are R 1 , R 2 , and B 1/2 positions (showing limited substitution pattern) ( Table 1).…”
Section: The Dataset and Descriptorsmentioning
confidence: 99%
“…Furthermore, R 2 pred may not be the only optimum criterion for selection of the variables; other factors like r 2 (squared correlation coefficient between observed and predicted values), r 2 0 (squared correlation coefficient between observed and predicted values with intercept value set to zero), and Root Mean Square Error of Prediction (RMSEP) [13] may be considered and variables should be selected based upon a suitable balance among all statistical parameters having values within their acceptable range. The present report tries to explore the optimum variable selection strategy in case of PLS regression using a model dataset of anti-HIV thiocarbamates [25]. The objective of this report is neither formulating new QSAR models for anti-HIV thiocarbamates nor com-paring the present models with the published ones.…”
Section: Introductionmentioning
confidence: 99%
“…The cytoprotection data of anti-HIV thiocarbamates (n ¼ 62) reported by Ranise et al [58] have been used as the model data set: the cytoprotection data (EC 50 (mM)) of substituted thiocarbamates (Table I) have been converted to the logarithmic scale (pEC 50 (mM)) and then used for subsequent QSAR analyses as the response variable. There are four regions of structural variations in the compounds: one is the R position on the phenyl ring (showing diverse substitution pattern), and the remaining are R 1 , R 2 and B 1/2 positions (showing limited substitution pattern) (Table I).…”
Section: The Data Setmentioning
confidence: 99%
“…The cytoprotection data reported by Ranise et al [20] have been used as the model dataset for the present QSAR study: the cytoprotection data [EC 50 (mM)] of substituted thiocarbamates (Table 1) (compound concentrations required to achieve 50% protection of MT-4 cells from HIV-1 induced cytopathogenecity) have been converted to the logarithmic scale [pEC 50 (mM)] and then used for subsequent QSAR analyses as the response variable. There are four regions of structural variations in the compounds: one is the R position of the phenyl ring (showing diverse substitution pattern), and the remaining are R 1 , R 2 and B 1/2 positions (showing limited substitution pattern) (Table 1).…”
Section: Methodsmentioning
confidence: 99%
“…In continuation of such efforts, the present paper deals with QSAR modeling of cytoprotection activity data of substituted thiocarbamates [20].…”
Section: Introductionmentioning
confidence: 99%